Aptus Endosystems Inc. Announces Positive Initial Data From ANCHOR Post-Market Registry

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

SUNNYVALE, Calif.--(BUSINESS WIRE)--Aptus Endosystems, Inc., a medical device company pioneering solutions to enhance aneurysm repair, today announced positive initial results from its ANCHOR post-market registry evaluating the use of the Heli-FX™ EndoAnchor System in endovascular aneurysm repair (EVAR). Heli-FX is a mechanical fastening device that connects the endograft to the aorta and is designed to enhance the long-term durability of the procedure and reduce the risk of repeat interventions in EVAR. These early results from the first 250 patients demonstrate the safety and acute technical success of utilizing Heli-FX in primary and revision EVAR procedures. These data were presented for the first time by James Joye, D.O., interventional cardiologist at El Camino Hospital, at the 11th VIVA conference held in Las Vegas, Nevada on October 8–11, 2013.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC